Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuro-Oncology

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/neuonc/not320PMID 24482446PMCID PMC3984557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience

  2013cited by this paper
• Role of high‐dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors

  2010cited by this paper
• Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.

  2010cited by this paper
• High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

  2010cited by this paper
• Topoisomerase I inhibitors in the treatment of primary CNS malignancies: an update on recent trends.

  2010cited by this paper
• Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy

  2009cited by this paper
• Promoter methylation and expression analysis of MGMT in advanced pediatric brain tumors.

  2009cited by this paper
• Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators

  2008cited by this paper
• Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression

  2008cited by this paper
• Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors

  2007cited by this paper
• Metastatic medulloblastoma in an adult; treatment with temozolomide.

  2007cited by this paper
• Temozolomide Treatment of an Adult with a Relapsing Medulloblastoma

  2007cited by this paper
• Temozolomide in resistant or relapsed pediatric solid tumors

  2006cited by this paper
• High-dose chemotherapy in children with newly-diagnosed medulloblastoma.

  2006cited by this paper
• Phase II trial of temozolomide in children with recurrent high-grade glioma

  2006cited by this paper
• Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.

  2006cited by this paper
• Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

  2005cited by this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

  2004cited by this paper
• Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.

  2003cited by this paper
• Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients

  2003cited by this paper
• Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human Primates

  2003cited by this paper
• Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors

  2003cited by this paper
• Childhood cancer survival in Europe and the United States

  2002cited by this paper
• Treatment of leptomeningeal relapse of medulloblastoma with temozolomide.

  2002cited by this paper
• Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

  2001cited by this paper
• Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.

  1999cited by this paper
• Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.

  1998influential reference
• Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

  1998influential reference
• High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.

  1998cited by this paper
• Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group.

  1998cited by this paper
• Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

  1997cited by this paper
• Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.

  1996cited by this paper
• Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

  1996cited by this paper
• Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

  1995cited by this paper
• The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

  1990cited by this paper
• Optimal two-stage designs for phase II clinical trials.

  1989cited by this paper
• Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

  1987cited by this paper

• Molecular features reflect clinical outcomes after recurrence in medulloblastoma: a single-institution experience

  2025cites this paper
• Real-life experience with a “modified-MEMMAT” regimen for relapsed medulloblastoma

  2025cites this paper
• Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial

  2023cites this paper
• Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

  2023cites this paper
• Efficacy and safety of bevacizumab, irinotecan, and temozolomide combination for relapsed or refractory pediatric central nervous system embryonal tumor: a single-institution study.

  2023cites this paper
• Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

  2022cites this paper
• Medulloblastoma and the DNA Damage Response

  2022cites this paper
• A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma

  2022cites this paper
• Medulloblastoma in adults – reviewing the literature from a surgeon’s point of view

  2021cites this paper
• Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma

  2021cites this paper
• Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment

  2021cites this paper
• An efficient and novel treatment regimen including temozolomide for medulloblastoma: a case study

  2021cites this paper
• Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report

  2021cites this paper
• Application of Genome-Wide DNA Methylation Analysis to Differentiate a Case of Radiation-Induced Glioblastoma From Late-Relapsed Medulloblastoma.

  2021cites this paper
• Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial

  2021cites this paper
• MEVITEM - A Phase I/II of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.

  2021cites this paper
• Pediatric Gastrointestinal Stromal Tumors and Neuroendocrine Tumors: Advances in Surgical Management.

  2021cites this paper
• Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion

  2020cites this paper
• Aggressive pituitary tumors in the young and elderly

  2020cites this paper
• DNA inhibitors for the treatment of brain tumors

  2020cites this paper
• Efficacy of Temozolomide in Children with Solid Tumors

  2020cites this paper
• Childhood Medulloblastoma: Old Challenges, New Perspectives

  2020cites this paper
• Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy

  2020cites this paper
• Cancer of the Central Nervous System

  2020cites this paper
• Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

  2020cites this paper
• Temozolomide and oral etoposide in children with recurrent malignant brain tumors

  2020cites this paper
• Neonatal pharmacology and clinical implications

  2019cites this paper
• Medulloblastoma: optimizing care with a multidisciplinary approach

  2019cites this paper
• Updates on Management of Adult Medulloblastoma

  2019cites this paper
• Adult medulloblastoma: an overview on current and future strategies of treatment

  2019cites this paper
• Cisplatin Toxicity in Children with Malignancy

  2019cites this paper
• Clinical Characteristics and Outcome of Children With Relapsed Medulloblastoma: A Retrospective Study at a Single Center in China

  2018cites this paper
• Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma.

  2018cites this paper
• Medulloblastoma

  2018cites this paper
• Chemotherapeutic Strategies in Brain Tumors

  2018cites this paper
• A primitive neuroectodermal tumor in an adult

  2018cites this paper
• Survival Following Tumor Recurrence in Children With Medulloblastoma

  2018cites this paper
• Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update

  2017cites this paper
• A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high‐risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group

  2017cites this paper
• Brain tumors in children. Intervening with the aftermath: relapse and long term side effects

  2017cites this paper
• Sophoridine suppresses cell growth in human medulloblastoma through FoxM1, NF-κB and AP-1.

  2017cites this paper
• Effect of O6-methylguanine-DNA methyltransferase methylation in medulloblastoma.

  2017cites this paper
• Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression

  2017cites this paper
• A prognostic analysis of primitive neuroectodermal tumor for postoperative recurrent patients and a literature review

  2016cites this paper
• Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)

  2016cites this paper
• Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response

  2016cites this paper
• Childhood medulloblastoma.

  2016cites this paper
• Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study

  2016cites this paper
• Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease

  2016cites this paper
• The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review

  2016cites this paper
• The evolution of the anaplastic cerebellar liponeurocytoma: case report and review of the literature.

  2015cites this paper
• The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.

  2015cites this paper
• Recent progresses in chemotherapy for pediatric brain tumors

  2014cites this paper